Clinical Study
Plasma 25-Hydroxyvitamin D Is Independently Associated with Hemoglobin Concentration in Male Subjects with Type 2 Diabetes Mellitus
Table 1
Clinical characteristics of subjects. Continuous variables are expressed as mean ± SD.
| Age (y/o) | 64.5 ± 12.2 | BMI | 25.2 ± 4.4 | Duration of diabetes mellitus (year) | 18.1 ± 11.1 | Fasting plasma glucose (mmol/L) | 9.7 ± 3.0 | HbA1c (%) | 7.8 ± 1.6 | Total cholesterol (mmol/L) | 4.76 ± 0.78 | HDL cholesterol (mmol/L) | 1.34 ± 0.35 | Triglyceride (mmol/L) | 1.85 ± 2.05 | Estimated GFR (mL/min/1.73 m2) | 54.5 ± 26.8 | Albumin creatinine ratio (mg/g Cr) | 852.7 ± 1426 | hs CRP (mg/dL) | 0.14 ± 0.40 | White blood cell count (mm3) | 7064 ± 1954 | Red blood cell count (×104/mm3) | 438 ± 64.8 | Hemoglobin (g/L) | 140 ± 19 | Hematocrit (%) | 40.3 ± 5.3 | Mean corpuscular volume (fl) | 92.2 ± 4.2 | 25-hydroxyvitamin D (ng/mL) | 27.5 ± 12.1 | Vitamin D binding protein (g/mL) | 316 ± 38.4 | Diabetic nephropathy (none/microalbuminuria/ macroalbuminuria/renal failure) | 18/35/29/24 | Diabetic retinopathy (none/background/more advanced stage or prior photocoagulation) | 43/44/19 | History of cardiovascular disease (none/positive) | 70/36 | Percentage of smoker (%) | 29.2 |
|
|